Abstract: An optical system affixed to an electronic apparatus is provided, including a first optical module, a second optical module, and a third optical module. The first optical module is configured to adjust the moving direction of a first light from a first moving direction to a second moving direction, wherein the first moving direction is not parallel to the second moving direction. The second optical module is configured to receive the first light moving in the second moving direction. The first light reaches the third optical module via the first optical module and the second optical module in sequence. The third optical module includes a first photoelectric converter configured to transform the first light into a first image signal.

Abstract: The invention discloses a method of manufacturing a lysin protein capable of directly lysing Acinetobacter baumannii without pretreatment processing using chloroform or EDTA, comprising: transforming an expression plasmid into E. coli, wherein the expression plasmid is deposited at DSMA-Deutsche Sammlung von Mikroorganismen and Zellkulturen with deposit number DSM32023; expressing the expressing plasmid by the E. coli to form lysin protein having an amino acid sequence as set forth in SEQ ID NO: 6; lysing the E. coli containing the lysing protein to obtain a supernatant by centrifugating the E. coli lysate; mixing the supernatant and Ni2+ resins, washing the unbound protein by a binding buffer containing 50 mM Tris-HCl (pH 8.2), 15 mM MgCl2, 20% (v/v) glycerol, 0.05% ?-ME and 0.1 mM PMSF; and eluting the purified lysing protein by an elution buffer containing 50 mM Tris-HCl (pH 8.2), 15 mM MgCl2, 20% (v/v) glycerol, 0.05% ?-ME, 0.1 mM PMSF and 250 mM imidazole.

Abstract: The invention discloses a purified lysin protein for lysing Acinetobacter baumannii cells without pretreatment process using chloroform or EDTA. The purified lysin protein includes a first peptide fragment and a second peptide fragment. The first peptide fragment has an amino acid sequence set forth as SEQ ID NO: 4 and the second peptide fragment has a amino acid sequence set forth as SEQ ID NO: 5.

Abstract: The present invention provides a hybridoma cell line (DSM ACC3145), wherein the hybridoma cell line produces an antibody which specifically binds to an amino acid sequence of type II collagen comprising: K-G-E-P-G-D-D-G-P-S-C (as set forth in SEQ ID NO. 1); and a method for detecting osteoarthritis, by identifying a presence of type II collagen in a urine sample through containing the urine sample with the said antibody.

Abstract: The present invention provides a hybridoma cell line (DSM ACC3145), wherein the hybridoma cell line produces an antibody which specifically binds to an amino acid sequence of type II collagen comprising: K-G-E-P-G-D-D-G-P-S-C (as set forth in SEQ ID NO. 1); and a method for detecting osteoarthritis, by identifying a presence of type II collagen in a urine sample through containing the urine sample with the said antibody.

Abstract: A therapy or prophylaxis of K. pneumoniae infections with a lytic bacteriophage specifically against K. pneumoniae, provides a lytic bacteriophage (DSM 24329) to a K. pneumoniae infected organism for the sake of relieving the serious complications of liver abscesses and bacteremia, and the high mortality rate of K. pneumoniae infections in Taiwan.

Abstract: A newly isolated lytic bacteriophage specifically against Klebsiella pneumoniae, deposited at DSMZ-Deutsche Sammlung von Mikroorganismen and Zellkulturen with deposit number (DSM 24329), shows broad host ranges and lytic effects on K. pneumoniae isolated from Taiwan under either in vivo or in vitro models.

Abstract: A system for determining concentration of a predetermined osteoarthritis biomarker in a urine sample includes first cell and first limiting elements, a quartz crystal microbalance (QCM) sensor device having a sample contacting side, and a monitoring device. The first cell element has a sensor confronting side formed with a recess portion. The first limiting element is disposed at the sensor confronting side, is disposed to surround the recess portion, contacts the sample contacting side, and cooperates with the recess portion and the sample contacting side to confine a sample receiving space for receiving the urine sample. The QCM sensor device includes a quartz resonator and an antibody applied to the quartz resonator and capable of binding with the biomarker, generates a concentration signal corresponding to mass of the biomarker that binds to the antibody, and is coupled to the monitoring device to provide the concentration signal thereto for processing thereby.

Abstract: A therapy or prophylaxis of K. pneumoniae infections with a lytic bacteriophage specifically against K. pneumoniae, provides a lytic bacteriophage (DSMZ 24329) to a K. pneumoniae infected organism for the sake of relieving the serious complications of liver abscesses and bacteremia, and the high mortality rate of K. pneumoniae infections in Taiwan.

Abstract: A newly isolated lytic bacteriophage specifically against Klebsiella pneumoniae, deposited at DSMZ-Deutsche Sammlung von Mikroorganismen and Zellkulturen with deposit number (DSM 24329), shows broad host ranges and lytic effects on K. pneumoniae isolated from Taiwan under either in vivo or in vitro models.